BofA analyst Sherif El-Sabbahy raised the firm’s price target on Legence (LGN) to $105 from $90 and keeps a Buy rating on the shares after the company delivered a “strong Q1” and backlog expanded to $5.4B from $3.7B in Q4. Following the report, the firm raised its adjusted EBITDA estimates 11% and 19% for 2026 and 2027, respectively.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN: